Faculty Information - SUZUKI Atsushi

（Last updated : 2025-05-20 12:22:49）

SUZUKI Atsushi
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Cardiology

Position Assistant Professor

■ Published papers

1.	Original article	Persistently low tricuspid annular plane systolic excursion and its prognosis in Japanese hospitalized patients with heart failure with reduced ejection fraction 2024/11/10
2.	Original article	Left Ventricular End-Systolic Diameter May Predict Persistent Heart Failure with Reduced Ejection Fraction. 2023/11
3.	Original article	Stratification of Destination Therapy Candidates by J-HeartMate Risk Score Among Elderly Non-Responders to Cardiac Resynchronization Therapy. 2022/08/26
4.	Original article	Impact of anatomical position of the inflow cannula on stroke in patients with left ventricular assist devices 2022/01
5.	Original article	Association between myocardial hypoxia and fibrosis in hypertrophic cardiomyopathy: analysis by T2* BOLD and T1 mapping MRI. 2020/03
6.	Original article	Changes in characteristics and outcomes in Japanese patients with heart failure from the 2000s to the 2010s: The HIJ-HF cohorts. 2020/03
7.	Original article	Development and Practical Test of Quality Indicators for Palliative Care in Patients With Chronic Heart Failure. 2020/01
8.	Original article	Long-term outcome of carvedilol therapy in Japanese patients with nonischemic heart failure. 2020/01
9.	Review article	Sudden death in heart failure 2019/11
10.	Original article	Development and validation of support tools for advance care planning in patients with chronic heart failure. 2019/10
11.	Original article	Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan. 2019/06
12.	Other	JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome. 2019/04
13.	Original article	Effects of Intravenous Landiolol on Heart Rate and Outcomes in Patients with Atrial Tachyarrhythmias and Acute Decompensated Heart Failure: A Single-Center Experience. 2019/03
14.	Case report	A case of desmoplakin mutation and delayed arrhythmogenic right ventricular cardiomyopathy/dysplasia after atrial septal defect closure. 2019/02
15.	Case report	Successfully treated eosinophilic granulomatosis with polyangiitis relapse presenting as myocarditis and followed by multimodality imaging. 2018/10
16.	Original article	Impact of Recurrent Ventricular Tachyarrhythmia on Outcome in Japanese Heart Transplant Candidates With a Left Ventricular Assist Device. 2018/08
17.	Original article	Body Mass Index and Sudden Cardiac Death in Japanese Patients After Acute Myocardial Infarction: Data From the JCAD Study and HIJAMI-II Registry. 2018/07
18.	Original article	Narrowing filtered QRS duration on signal-averaged electrocardiogram predicts outcomes in cardiac resynchronization therapy patients with nonischemic heart failure. 2018/05
19.	Original article	Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling. 2018/01
20.	Original article	Effectiveness and safety of dabigatran versus warfarin in real-world Japanese patients with atrial fibrillation: A single-center observational study 2017/04
21.	Other	Guidelines for Therapeutic Drug Monitoring of Cardiovascular Drugs Clinical Use of Blood Drug Concentration Monitoring (JCS 2015) - Digest Version. 2017/03
22.	Original article	Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging. 2017/02
23.	Original article	The Role of IL17 and IL17+Th17 in the Atherosclerotic Development and renal dysfunction 2017
24.	Case report	Isolated cardiac sarcoidosis diagnosed by electroanatomic voltage mapping-guided endomyocardial biopsy combined with magnetic resonance imaging and positron emission tomography 2016/10
25.	Original article	Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience. 2016/07
26.	Original article	Assessment of Criteria of Ventricular Late Potential Measurement Using 187-channel Signal-averaged Vector-projected High-resolution Electrocardiograph 2016/06
27.	Original article	Renal Function and Treatment Persistence with Non-Vitamin K Antagonist Oral Anticoagulants in Japanese Patients with Atrial Fibrillation:A Single-Center Experience 2016/05
28.	Case report	Combination therapy with corticosteroid and mycophenolate mofetil in a case of refractory cardiac sarcoidosis. 2016/04
29.	Review article	Steroid Therapy Ameliorated Myocardial Fatty Acid Metabolism With Recovery of Complete Atrioventricular Block in Cardiac Sarcoidosis. 2016/04
30.	Original article	An overlap of Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy/dysplasia. 2016/02
31.	Original article	Long-Term Prognostic Role of the Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia 2016/02
32.	Original article	Sudden cardiac arrest secondary to cardiac amyloidosis in a young woman with cryopyrin-associated periodic syndrome. 2015/04
33.	Original article	Effect of intravenous amiodarone on QT and T peak-T end dispersions in patients with nonischemic heart failure treated with cardiac resynchronization-defibrillator therapy and electrical storm Original Research Article. 2015/02
34.	Original article	Impact of clustered depression and anxiety on mortality and rehospitalization in patients with heart failure. 2014/12
35.	Original article	Impact of the serum bone-specific alkaline phosphatase level at the initiation of hemodialysis therapy for end-stage renal disease on cardiovascular events. 2014/07
36.	Original article	Effects of flecainide on left ventricular pressure gradient and symptoms in obstructive hypertrophic cardiomyopathy: a comparison of flecainide and disopyramide. 2014/06
37.	Original article	THE ROLE OF PSGL-1-EXPRESSING CD4 T CELLS IN THE DEVELOPMENT OF ATHEROSCLEROSIS. 2014
38.	Original article	Reversible cardiomyopathy after radiofrequency ablation of 30-year persistent atrial tachycardia. 2013/12
39.	Original article	Lack of Pharmacokinetic Interaction between Pilsicainide and Rifampicin in Healthy Volunteers 2013/08
40.	Original article	Contributing factors to the apparent clearance of bepridil in patients with paroxysmal or persistent atrial fibrillation: analysis using population pharmacokinetics 2013/06
41.	Original article	Impact of diastolic dysfunction on the outcome of catheter ablation in patients with atrial fibrillation 2013/03
42.	Other	Renal Dysfunction, Recovery Time Dispersion and Ventricular Arrhythmias in Heart Failure Patients Receiving Cardiac Resynchronization Therapy Defibrillator 2011/09
43.	Original article	Clinical outcome in paroxysmal or persistent atrial fibrillation patients receiving bepridil. 2011/06
44.	Other	Evaluation of the Clinical Implication of T-wave Alternans by Time-domain Modified Moving Average Analysis in Routine Exercise Testing 2010
45.	Original article	Gender difference in arrhythmic occurrences in patients with nonischemic dilated cardiomyopathy and implantable cardioverter-defibrillator 2010
46.	Other	Impact of appropriate shock therapy in nonischemic heart failure patients with prophylactic implantable cardioverter defibrillator 2010
47.	Other	Impact of renal dysfunction on mortality in heart failure patients receiving cardiac resynchronization therapy 2010
48.	Other	Indication andefficacy of cardiac resynchronization therapy in heart failure patients who had not met criteria Symposium 8 indication and unsolved issues in cardiac resynchronization therapy 2010
49.	Original article	Interlead difference between T-peak to T-end intervals in resynchronization patients with an implantable cardioverter-defibrillator 2010
50.	Other	Is reduced left ventricular ejection fraction sufficient to predict of sudden cardiac death in patients with structural heart disease? Plenary session 3 ;cardiac suddeen death:clinical evidence and treatment 2010
51.	Case report	Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia 2010
Display 5 items
Display all(51)

■ Academic conference presentation

1.	Hub and Spoke Model of Cardiogenic Shock Patients: The Role of Hub Hospital （Speech） 2024/03/09
2.	Persistent right ventricular dysfunction in heart failure patients with reduced ejection fraction （Speech，General） 2023/03
3.	The Possibility of Destination Therapy for Elderly Non-responder of Cardiac Resynchronization Therapy （Speech，General） 2021/03/29
4.	Clinical Features of Deteriorating Cardiogenic Shock Patients （Speech） 2021/03/28
5.	Characteristics of Advanced Heart Failure Patients Candidate to Ventricular Assist Devices as Destination Therapy （Speech，Panelist at Symposium/Workshop (Other)） 2021/03/26
6.	Factors Associated With Ejection Fraction Improvement Among Hospitalized Heart Failure Patients With Reduced Ejection Fraction （Poster notice，General） 2019/11/17
7.	Observational Report of the Prognostic Impact of Landiolol in Acute Heart Failure patients Presenting Atrial Fibrillation with Rapid Ventricular Response （Poster notice，General） 2019/11/17
8.	A case of chronic thromboembolic pulmonary hypertension in systemic sclerosis （Poster notice，General） 2019/10/05
9.	A case with ischemic severe heart failure improved temporary after Autologous myoblast sheets transplantation therapy, but we could not save （Poster notice，General） 2019/10/04
10.	Changes of ejection fraction among hospitalized heart failure patients: From HIJ-HFII study （Poster notice，General） 2019/10/04
11.	Relationship between B-type natriuretic peptide and various adverse outcomes in patients with apical hypertrophic cardiomyopathy （Speech，General） 2019/10/04
12.	Benefit of sinus rhythm restoration in acute decompensated heart failure patients with atrial tachyarrhythmia treated with landiolol （Abstract Only，General） 2019/09/02
13.	Change in left ventricular ejection fraction and outcome in heart failure patients with mid-range ejection fraction: from the HIJ-HF prospective study （Poster notice，General） 2019/09/02
14.	Myocardial flow reserve using 13N ammonia PET for detection of cardiac allograft vasculopathy in heart transplant patients （Poster notice，General） 2019/09/02
15.	The Impact of Brain Atrophy in the Patient with Young Patients with Severe Heart Failure （General） 2019/09/02
16.	Incidence and Predictors of Long-term Renal Function Deterioration after Implantation of a Centrifugal, Continuous-flow Device for Bridge to Transplant （Speech，General） 2019/04/05
17.	Myocardial Flow Reserve Using 13N Ammonia PET for Detection of Cardiac Allograft Vasculopathy （Poster notice，General） 2019/04/03
18.	Haemoglobin A1c (HbA1c) in Diabetic Patients with Myocardial Infarction: Is HbA1c an Independent Risk Factor and Predictor of Adverse Outcome? （Speech，General） 2019/03/31
19.	Usefulness of Wearable Cardioverter Defibrillator as a Bridge Therapy （Poster notice，General） 2019/03/31
20.	13N Ammonia PET Myocardial Flow Reserve for Detection of Cardiac Allograft Vasculopathy in Heart Transplant Patients （Speech，General） 2019/03/30
21.	Detection of Myocardial Inflammation in Sarcoidosis Using Cardiac Magnetic Resonance T2 Mapping （Speech，General） 2019/03/30
22.	Management of Ventricular Arrhythmias in Patients with Implanted Ventricular Assist Devices （Speech，General） 2019/03/30
23.	Prognostic Impact of Discharge Serum Chloride Levels in Heart Failure Patients: An Analysis of HIJ-HF II Multicenter Cohort Study （Poster notice，General） 2019/03/30
24.	Renal Function and the Prognostic Impact of Renin-angiotensin-aldosterone System Inhibitors for Heart Failure Patients: An Analysis of HIJ-HF II Study （Speech，General） 2019/03/29
25.	Aggressive Sodium Restriction in Chronic Heart Failure: 6g vs. 3g a Randomized Study （Poster notice，General） 2019/03/16
26.	A new treatment option with ipragliflozin administered additionally in a caseinvolving stage D heart failure with diabetes （Speech，General） 2018/10/13
27.	Treatment strategy for Cpc-PH after surgery of mitral valve disease; Insights from a case report （Speech，General） 2018/10/13
28.	A Case of Severe Aortic Stenosis with Mitral Regurgitation Decreased after Transcatheter Aortic Valve Implantation （Poster notice，General） 2018/10/11
29.	Cardiac Resynchronization Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy/dysplasia: Case Reports and Clinical Implications （Speech，General） 2018/10/11
30.	Impact of congestion in worsening renal failure after implantation of a centrifugal, continuous-flow left ventricular device （Speech，General） 2018/08/27
31.	Clinical and Electrocardiographic Characteristics in High-Risk Hypertrophic Cardiomyopathy Patients with Prophylactic Implantable Cardioverter Defibrillator （Speech，Panelist at Symposium/Workshop (Appointed)） 2018/07/13
32.	Impact of nutritional status on heart failure hospitalization and mortality in nonischemic patients with implantable cardioverter defibrillator （Poster notice，General） 2018/05/26
33.	Temporal trends in clinical characteristics, management of heart failure patients with mid-range ejection fraction in Japan: from the HIJ-HF studies （Poster notice，General） 2018/05/26
34.	The impact of Brain atrophy in the young patients with severe heart failure （Speech，General） 2018/05/26
35.	Use of mineralocorticoid receptor antagonists in real-world patients with nonischemic heart failure and reduced ejection fraction: an analysis of HIJ-HF II study （Poster notice，General） 2018/05/26
36.	The impact of Brain atrophy in the young patients with severe heart failure （Speech，General） 2018/05/19
37.	Long-Term Changes in Renal Function after Implantation of a Centrifugal-type, Continuous-flow Left Ventricular Assist Device （Speech，General） 2018/03/25
38.	Use of Mineralocorticoid Receptor Antagonists in Real-world Heart Failure Patients with Reduced Ejection Fraction: An Analysis of HIJ-HF II Study （Speech，General） 2018/03/25
39.	Impact of Nutritional Status on Heart Failure Hospitalization and Mortality in Patients with Implantable Cardioverter Defibrillator （Poster notice，General） 2018/03/24
40.	Long-term Survival in Heart Failure Patients Receiving Carvedilol Therpay: A 10-Year Observational Study （Poster notice，General） 2018/03/24
41.	Comprehensive Targeted Sequencing Uncovers the Genetic Basis of Cardiomyopathy and the Genotypes Involved in Prognosis and Left Ventricular Reverse Remodeling （Speech） 2018/03/23
42.	Impact of Nutritional Status on Mortality in Patients with Cardiac Resynchronization Therapy （Poster notice，General） 2018/03/23
43.	Role of Pharmacotherapy on Reducing Sudden Death in Patients with Heart Failure. （Speech，Panelist at Symposium/Workshop (Appointed)） 2018/03/23
44.	The Impact of Brain Atrophy in the Patient with Young Patients with Severe Heart Failure （Poster notice，General） 2018/03/11
45.	Importance of physiological pacing on right heart failure in a case with left ventricular noncompaction and left ventricular assist device （Speech，General） 2017/10/13
46.	Long-term changes in renal function in patients after implantation of a centrifugal-type, continuous-flow left ventricular assist device （Speech，Panelist at Symposium/Workshop (Applied)） 2017/10/13
47.	Outcome of Severe Ischemic Heart Failure Patients Treated with Amiodarone （Poster notice，General） 2017/10/13
48.	Pharmacologic management of arrhythmia in heart failure （Speech，Panelist at Symposium/Workshop (Appointed)） 2017/10/12
49.	The impact of Brain atrophy in the patient with young patients with severe heart failure （Speech，General） 2017/10/12
50.	Short-term prevalence of fatal ventricular arrhythmic events in patients with newly diagnosed reduced left ventricular ejection fraction （Poster notice，General） 2017/08/29
51.	Changes and predictive value of filtered QRS duration for mortality in non-ischemic heart failure patients with cardiac resynchronization therapy （Poster notice，General） 2017/04/30
52.	Echocardiographically estimated pulmonary artery systolic pressure predicts progressive heart failure and systemic embolic events in patients with hypertrophic cardiomyopathy （Poster notice，General） 2017/04/30
53.	Blood Urea Nitrogen to Albumin Ratio Predicts Mortality of Heart Failure Patients with Cardiac Resynchronization Therapy （Poster notice，General） 2017/03/19
54.	Heart Team Approach for LVAD - Cooperation with Home Medical Care - （Speech，Panelist at Symposium/Workshop (Applied)） 2017/03/19
55.	Impact of Core Depressive Symptom in Outpatients with Heart Failure: A Multicenter Prospective Observational Patient Health Questionnaire Study. （Poster notice，General） 2017/03/19
56.	Recovery of Left Ventricular Ejection Fraction and Ventricular Arrhythmias in Heart Failure Patients: Prospects of Wearable Cardioverter Defibrillator （Speech，Panelist at Symposium/Workshop (Applied)） 2017/03/19
57.	Adherence to Medication and Characteristics in Patients with Cardiovascular Disease. From A Multicenter Prospective Observational Depression Study （Speech，General） 2017/03/18
58.	Adverse Effect of Underuse of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Therapy in Elderly Patients Hospitalized with Heart Failure （Poster notice，General） 2017/03/18
59.	Blood Urea Nitrogen to Albumin Ratio Predicts Mortality of Japanese Heart Failure Patients: From the HIJ-HF Cohort Study （Speech，General） 2017/03/18
60.	Activation of Effector Memory and Effecter T Cells in Patients with Heart Failure （Poster notice，General） 2017/03/17
61.	Arrhythmogenic Right Ventricular Cardiomyopathy with a Desmoplakin Mutation That Appeared after Occlusion of an Atrial Septal Defect （Speech，General） 2017/03/17
62.	Long-Term Recovery of Left Ventricular Ejection Fraction in Heart Failure Patients with Primary Prevention Implantable Cardioverter Defibrillator （Poster notice，General） 2017/03/17
63.	Prognostic Factors in Japanese Elderly Heart Failure with Preserved Ejection Fraction: From the HIJ-HF II Cohort Study （Speech，General） 2017/03/17
64.	Short-term Prevalence of Fatal Ventricular Arrhythmic Event in Patients with Newly-diagnosed Reduced Ejection Fraction （Poster notice，General） 2017/03/17
65.	Activation of Effector Memory T Cells in Patients with Heart Failure （Speech，General） 2016/12/17
66.	The roll of potassium channel on T cell for effector memory and effecter T cells in patients with heart failure （Speech，Panelist at Symposium/Workshop (Applied)） 2016/12/07
67.	Beta-blockers and Prognosis in Patients with Atrial Fibrillation and Heart Failure: From the HIJ-HF Cohort （Speech，Panelist at Symposium/Workshop (Applied)） 2016/10/09
68.	A Case of Dilated Cardiomyopathy Demonstrating Markedly Improvement from Deteriorated Renal Function by Challenging Catecholamine Infusion and Succeeding an Implantable-VAD （Poster notice，General） 2016/10/08
69.	Short-term Prevalence of Fatal Ventricular Arrhythmic Event in Patients with Newly-diagnosed Reduced Ejection Fraction （Poster notice，General） 2016/10/08
70.	Blood Urea Nitrogen to Albumin Ratio Predicts Mortality of Heart Failure with Preserved Ejection Fraction: From the HIJ-HF cohort study （Speech，General） 2016/10/07
71.	Restrictive Left Ventricular Filling Pattern and Sudden Death Risk in Japanese Patients with Hypertrophic Cardiomyopathy （Poster notice，General） 2016/10/07
72.	A novel indication of cardiac resynchronization therapy without cardioversion and defibrillation （Poster notice，General） 2016/08/30
73.	Electrocardiographic risk stratification of electrical storm in non-ischemic heart failure patients with cardiac resynchronization （Poster notice，General） 2016/08/30
74.	Impact of PHQ-2 screening in outpatients with heart failure: A Multicenter prospective observational study （Poster notice，General） 2016/08/30
75.	Impact of ventricular tachyarrhythmias in advanced non ischemic heart failure patients who referred for heart transplant evaluation （Poster notice，General） 2016/08/29
76.	Single photon emission computed tomography is the marker of cardiac event risk in cardiac sarcoidosis patients （Poster notice，General） 2016/08/29
77.	Nonsustained ventricular tachycardia in cardiac sarcoidosis is the independent marker of increased cardiac event （Poster notice，General） 2016/08/28
78.	A novel indication of cardiac resynchronization therapy without cardioversion and defibrillation （Speech，Panelist at Symposium/Workshop (Applied)） 2016/07/16
79.	Comparison of outcomes in patients received cardiac resynchronization therapy with and without defibrillator: a propensity-score adjusted analysis （Speech，Panelist at Symposium/Workshop (Applied)） 2016/07/16
80.	Risks for survival to hospital discharge in patients with intravenous class III antiarrhythmic drug for the termination of ventricular tachyarrhythmia （Speech，General） 2016/07/16
81.	Role of pharmacologic therapy for arrhythmia in heart failure （Speech，Panelist at Symposium/Workshop (Applied)） 2016/07/16
82.	The prognostic and therapeutic target role of atrial tachyarrhytmia in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia （Speech，Panelist at Symposium/Workshop (Applied)） 2016/07/16
83.	Possible Life-saving Effect of Implantable Cardioverter Defibrillator Therapy in Hypertrophic Cardiomyopathy Patients with Midventricular Obstruction （Speech，General） 2016/03/20
84.	Ventricular Tachycardia is a Significant Prognostic Factor in Patients with Cardiac Sarcoidosis Regardless of Corticosteroid Therapy （Speech，General） 2016/03/20
85.	Activation of Central Effector Memory and Effecter T Cells in Patients with Heart Failure （Speech，General） 2016/03/19
86.	Electrocardiographic Risk Stratification of Electrical Storm in Heart Failure Patients with Cardiac Resynchronization （Speech，General） 2016/03/19
87.	Pharmacological Prevention of Paroxysmal Atrial Fibrillation Recurrences in Symptomatic Patients. A Multicenter Crossover Study of Flecainide and Pilsicainide （Poster notice，General） 2016/03/19
88.	Prognostic Role of Atrial Tachyarrhythmias in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasi （Poster notice，General） 2016/03/19
89.	Impact of "Reactive" Pulmonary Hypertension in Severe Heart Failure Patients Who Referred for Heart Transplantation Evaluation in Japan （Poster notice，General） 2016/03/18
90.	Implantable Cardioverter Defibrillator in Heart Failure Patients with End-stage Renal Disease on Dialysis （Speech，Panelist at Symposium/Workshop (Applied)） 2015/10/23
91.	Clinical Features of Japanese Hypertrophic Cardiomyopathy Patients with Stroke and Systemic Embolic Events （Speech，General） 2015/04/26
92.	Atrial Arrhythmia is a Marker of Disease Progression in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia （Poster notice，General） 2015/04/24
93.	Clinical Phases Vary with Disease Stage in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia （Speech，General） 2015/04/24
94.	Amiodarone Treatments Improve the Effector Function of Memory T Cells in Heart Failure （Speech，General） 2014/12/12
95.	Amiodarone Treatments Improve the Inflammation in Heart Failure. （Poster notice，General） 2014/11/18
96.	Predictive Value of Pulmonary Capillary Wedge Pressure for Heart Failure Hospitalization in Heart FPatients with Cardiac Resynchronization Therapy. （Speech，General） 2014/10/12
97.	Weaning From Intropic Support in Severe Heart Failure Patients Who Referred for Heart Transplantation Evaluation. （Speech，General） 2014/10/11
98.	Significance of interlead difference of tpeak-end intervals and t-wave current density alternans in long QT syndrome with icd implantation. （Poster notice，General） 2014/09/01
99.	Proarrhythmic effect of cardiac resynchronization therapu and transmural dipersion in patients with nonischemic heart failure. （Poster notice，General） 2014/08/31
100.	Useful parameter of myocardial fatty acid metabolism and blood flow mismatch for the diagnosis and the detection of myocardial injury in active cardiac sarcoidosis. （Poster notice，General） 2014/08/31
101.	Proarrhythmic effect of cardiac resynchronization therapy and transmural dipersion in patients with nonischemic heart failure. （Poster notice，General） 2014/08/30
102.	Ventricular fibrillation in a young woman with cryopyrin-associated periodic syndrome. （Speech，General） 2014/08/30
103.	Long-term outcome of patients with obstructive hypertrophic cardiomyopathy with dual-chamber pacing （Poster notice，General） 2014/05/20
104.	Association between heart and ventricular arrhythmias in non-ischemic heartfailure patients receving implantable cardioverter defibrillators. （Poster notice，General） 2014/05/17
105.	Association between heart rate and ventricular arrhythmias in non-ischemic heart failure patients receiving implantable cardioverter defibrillator. （Poster notice，General） 2014/05/17
106.	Amiodarone Treatments Improve the Inflammation in Heart Failure Patient （Speech，General） 2014/03/23
107.	Blood Urea Nitrogen/Creatinine Ratio Predict Response to Tolvaptan in Hospitalized Decompensated Heart Failure Patients （Poster notice，General） 2014/03/21
108.	Changes and Predictive Value of QRS Duration for Mortality in Heart Failure Patients with Cardiac Resynchronization Therapy （Speech，General） 2014/03/21
109.	Necessity of a Comprehensive Treatment Approach for Heart Failure Patients （Speech，Panelist at Symposium/Workshop (Other)） 2014/03/21
110.	Amiodarone Treatments Improve the Inflammation in Heart Failure Patients with Nonischemic Cardiomyopathy （Poster notice，General） 2013/12/11
111.	Two-Dimensional Dominant High-Frequency Map and Disease Characterization by 187ch Signal-Averaged Vector-Projection ECG （Speech，General） 2013/07/05
112.	Effect of persistent renal impairment on mortality in cardiac resynchronization therapy patients with nonischemic heart failure （Poster notice，General） 2013/05/27
113.	Treatment Target to Prevent the Occurrence of Life-Threatening Arrhythmia in Patients with Impaired Left Ventricular Function （Speech，Panelist at Symposium/Workshop (Other)） 2013/03/16
114.	New Algorithm for a Characterization of high-frequency Signals and Two-dimensional Dominant Frequency Map by 187ch Signal-averaged Vector-projection ECG （Poster notice，General） 2013/03/15
115.	PSGL-1+ CD4+ T Cells Contribute Atherosclerotic Plaque Instability （Speech，General） 2012/12/07
116.	Tpeak-tend dispersion and the occurrence of ventricular tachyarrhythmia in nonischemic heart failure patients receiving cardiac resynchronization therapy （Poster notice，General） 2012/08/27
117.	Occurrence and Risks of Life-threatening Arrhythmia in Heart Failure Patients with Cardiac Resynchronization Therapy （General） 2012/03/17
118.	INFγ and IL-17-Producing T-Cells Contribute to the Microalbuminuria with the Dysfunction of Podocytes （Poster notice，General） 2012/03/16
119.	Renal dysfunction,recovery time dispersion and ventricular arrhythmias in heart failure patients receiving cardiac resynchronization therapy defibrillator （Poster notice，General） 2011/09/20
120.	A case of 30 year-lasting atrial tachycardia induced cardiomyoapthy （Speech，General） 2011/08/28
121.	Usefulness of Speckle Tracking Echocardiography in Patient Selection for Cardiac Resynchronization Therapy 2011/08/04
122.	The Model for End-Stage Liver Disease Score as an Independent Predictor of Outcomes in Cardiac Resynchronization Therapy （Speech，General） 2011/03/18
Display 5 items
Display all(122)

■ Education

1.	2006/04～2010/03	Faculty of Medicine, Tokyo Women's Medical University, Completed,
2.	1995/04～2001/03	Faculty of Medicine, Akita University, Graduated,